Alembic Pharmaceuticals Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alembic Pharmaceuticals Ltd with three other
companies in this sector in INDIA :
Abbott India Limited
sales of 40.93 billion Indian Rupees [US$545.21 million]
IPCA Laboratories Limited
(46.49 billion Indian Rupees [US$619.21 million]
Divi's Laboratories Limited
(53.94 billion Indian Rupees [US$718.54 million]
Alembic Pharmaceuticals Ltd reported sales of 46.06 billion Indian Rupees (US$613.49 million)
March of 2020.
increase of 17.1%
versus 2019, when the company's sales were 39.35 billion Indian Rupees .
This was the third consecutive year of growth at Alembic Pharmaceuticals Ltd.
Sales of Formulations saw an increase
23.2% in 2020, from
31.65 billion Indian Rupees to 38.98 billion Indian Rupees .
Not all segments of Alembic Pharmaceuticals Ltd experienced an increase in sales in 2020:
sales of Api fell 8.1% to 7.08 billion Indian Rupees .